Table 2. Serotype-specific carriage rate by vaccination status.
Serotype | Vaccinated (3 doses) | Unvaccinated (0 dose) | p-value |
---|---|---|---|
N = 1810 | N = 588 | ||
PCV10-types | n (%) | n (%) | |
1 | 1 (0.1) | 1 (0.2) | 0.402 |
4* | 3 (0.2) | 4 (0.7) | 0.045 |
6B | 37 (2.0) | 20 (3.4) | 0.061 |
9V/9A * | 14 (0.8) | 13 (2.2) | 0.004 |
14 | 27 (1.5) | 4 (0.9) | 0.130 |
18C/18F/18B/18A | 25 (1.4) | 9 (1.5) | 0.790 |
19F * | 22 (1.2) | 16 (2.7) | 0.011 |
23F | 51 (2.8) | 20 (3.4) | 0.468 |
Additional PCV-13 specific types | |||
3 | 2 (0.1) | 1 (0.2) | 0.723 |
6A * | 108 (6.0) | 49 (8.3) | 0.044 |
19A * | 100 (5.5) | 20 (3.4) | 0.040 |
NVT serotypes | |||
13 | 44 (2.4) | 17 (2.9) | 0.538 |
20 | 5 (0.3) | 0 (0) | 0.202 |
21 | 30 (1.7) | 9 (1.5) | 0.833 |
31 | 3 (0.2) | 0 (0) | 0.323 |
34 | 48 (2.7) | 14 (2.4) | 0.719 |
10A | 106 (5.9) | 23 (4.0) | 0.069 |
10F/10C/33C | 19 (1.1) | 9 (1.5) | 0.346 |
11A/11D * | 84 (4.6) | 12 (2.0) | 0.005 |
12F/12A/44/46 | 12 (0.7) | 5 (0.9) | 0.638 |
15B/15C | 110 (6.1) | 27 (4.6) | 0.178 |
15F/15A | 24 (1.3) | 8 (1.4) | 0.949 |
16F | 43 (2.4) | 13 (2.2) | 0.818 |
17F | 33 (1.8) | 6 (1.0) | 0.181 |
22F/22A | 11 (0.6) | 4 (0.7) | 0.846 |
23A | 22 (1.2) | 6 (1.0) | 0.702 |
23B | 37 (2.4) | 16 (2.7) | 0.332 |
24F/24A/24B | 16 (0.9) | 4 (0.7) | 0.637 |
33F/33A/37 | 19 (1.1) | 6 (1.0) | 0.952 |
35A/35C/42 | 19 (1.1) | 5 (0.9) | 0.673 |
35B | 57 (3.2) | 13 (2.2) | 0.240 |
35F/47F | 4 (0.2) | 1 (0.2) | 0.814 |
38/25F/25A | 13 (0.7) | 1 (0.2) | 0.130 |
6C | 21(1.2) | 6 (1.0) | 0.780 |
6D | 18 (1.0) | 10 (1.7) | 0.166 |
7C/7B/40 | 29 (1.6) | 11 (1.9) | 0.659 |
9N/9L * | 9 (0.5) | 23 (3.9) | <0.001 |
2 | 1 (0.1) | 0 (0) | 0.569 |
8 | 3 (0.2) | 1 (0.5) | 0.146 |
All PCV10-types (VT) * | 180 (9.9) | 87 (14.8) | 0.001 |
Non-PCV10-types (NVT)* | 1194 (66.0) | 351 (59.7) | 0.006 |
Non-PCV13-types | 984 (54.3) | 281 (47.7) | 0.450 |
*p-value less than 0.05.